UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
The HELLP syndrome. Clinical course, underlying disorders and long-term
follow-up
van Pampus, M.G.
Publication date
1999
Link to publication
Citation for published version (APA):
van Pampus, M. G. (1999). The HELLP syndrome. Clinical course, underlying disorders and
long-term follow-up.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.
Contents
Part I Clinical course of the (H)ELLP syndrome
Chapter 1 Introduction 9 Chapter 2 Maternal outcome following temporizing management of the 19
(H)ELLP syndrome
MG van Pampus, H Wolf, A Ilsen, PE Treffers Hypertension in Pregnancy 1999 (in press)
Severe maternal complications mostly occur at the onset of the (H)ELLP syndrome and are not always preventable
Chapter 3 Maternal and perinatal outcome after expectant management of 31 the HELLP syndrome compared with preeclampsia without HELLP
syndrome
MG van Pampus, H Wolf, SM Westenberg, JAM van der Post, GJ Bonsei, PE Treffers
European Journal of Obstetrics and Gynaecology and Reproductive Biology 1998;76:31-6
Obstetrical & Gynecological Survey 1998;53:462-4
Gestational age at the onset of the HELLP syndrome and the severity of hypertension are the best predictors of adverse perinatal outcome
Chapter 4 Perinatal results of hemodynamic and conservative temporizing 45 treatment in severe preeclampsia
W Visser, MG van Pampus, PE Treffers, HCS Wallenburg European Journal of Obstetrics and Gynaecology and Reproductive Biology 53; 1994:175-181
A retrospective comparison of maternal and neonatal outcome after temporizing treatment with and without plasma volume expansion did not demonstrate statistically significant differences
Part II Underlying disorders in preeclampsia and (H)ELLP syndrome
Chapter 5 High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
MG van Pampus, GA Dekker, H Wolf, PC Huijgens, MMW Koopman, BME von Blomberg, HR Büller
American Journal of Obstetrics and Gynecology 1999; 180:1146-50 Severe early-onset preeclampsia can be the first manifestation of thrombotic disease
Chapter 6 Prothrombin 20210 G-A mutation and Factor V Leiden mutation in 69 patients with a history of severe preeclampsia and (H)ELLP syndrome
MG van Pampus, H Wolf, MMW Koopman, A van den Ende, HR Büller, PH Reitsma
submitted for publication
Prothrombin 20210 G-A mutation and factor V Leiden mutation are associated with thrombotic risk, but not with perinatal mortality in women with a history of severe preeclampsia
Chapter 7 Lipoprotein (a) concentrations in patients with a history of severe 77 preeclampsia; a case control study
MG van Pampus, MMW Koopman, H Wolf, HR Büller, MH Prins, A van den Ende
Thrombosis and Haemostasis 1999;82:10-13
Women with a history of severe preeclampsia have high lipoprotein (a) levels, while women with a history of (H)ELLP syndrome do not
Part III Follow up of women with a history of (H)ELLP syndrome
Chapter 8 Long-term follow-up in patients with a history of a (H)ELLP syndrome 89 MG van Pampus, H Wolf, G Mayruhu, PE Treffers, OP Bleker
submitted for publication
(H)ELLP syndrome is a severe complication of pregnancy with both short and long-term sequelae
Chapter 9 Summary, conclusions and implications for future research 99 Samenvatting, conclusies en richtlijnen voor vervolgonderzoek
Co-Authors Dankwoord
117 119
